Abstract
New research on Oncology - Lung Cancer is the subject of a report. According to news reporting from Shanghai, People’s Republic of China, by NewsRx journalists, research stated, “Accurate, noninvasive, and reliable assessment of epidermal growth factor receptor (EGFR) mutation status and EGFR molecular subtypes is essential for treatment plan selection and individualized therapy in lung adenocarcinoma (LUAD). Radiomics models based on F-FDG PET/CT have great potential in identifying EGFR mutation status and EGFR subtypes in patients with LUAD.”
NETL
NSTL
Wiley